
Cyra D Capsule (10 Cap)
Salt Composition: Domperidone (30mg) + Rabeprazole (20mg)
Expiry Date: 01/2028
Inclusive of all taxes
10 Cap

Cyra D Capsule (10 Cap)
10 Cap
Rabeprazole + Domperidone
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Storage
Below 25°C
Expiry Date
01/2028
Marketer
systopic laboratories pvt. ltd.
Brand
Systopic Laboratories Pvt. Ltd.
5966.png&w=1920&q=75)
MAGIC DEALS
Enquire
Apply Promo Code
Available CouponsCyra D Capsule (10 Cap)
Inclusive of all taxes
In Stock
Authorized
Global Reach
Verified Logistics
The price displayed is inclusive of applicable taxes. Any additional fee (such as shipping fee, handling and/or platform fee etc.) will be clearly disclosed before you complete your purchase.
About The Product
Overview
The Cyra-D capsule has two medicines in it: rabeprazole sodium 20 mg and domperidone 30 mg per capsule, in strips of 10. Rabeprazole is a proton pump inhibitor that cuts stomach acid.
Domperidone helps the stomach and gut move food along. One seller says the domperidone is split into 10 mg immediate release and 20 mg sustained release.
Systopic Laboratories is the maker. Domperidone present in the Cyra-D capsule needs extra care.
It has serious heart rhythm problems, and it is barred from usage in heart disease, in pregnancy, and during breastfeeding.
Quick Product Facts
Item | Detail |
Active ingredients | Rabeprazole sodium 20 mg (enteric-coated pellets) + domperidone 30 mg per capsule |
Maker and pack | Systopic Laboratories Pvt Ltd, per most listings; one lists Lupin. Strip of 10 capsules |
Drug classes | Proton pump inhibitor and dopamine antagonist (prokinetic) |
Dose (same composition) | One capsule once daily, preferably before a meal |
Storage | Store Cyra-D capsules below 25°C in a cool, dry place, away from direct sunlight, heat, and moisture. |
Prescription status | Prescription only |
Uses and Indications
Torrent Veloz D (2022): gastro-oesophageal reflux not responding to rabeprazole alone.
Cipla Rabicip D: reflux disease (GERD) not responding to rabeprazole alone
Torrent Repral-D: GERD not adequately treated with a proton pump inhibitor or an H2 blocker alone, one capsule a day for 4 to 8 weeks
How It Works
Rabeprazole present in Cyra-D Capsules blocks the acid pump (H+/K+-ATPase) in the stomach lining. After a 20 mg dose, the effect starts within an hour and peaks in 2 to 4 hours. Acid output 23 hours after the first dose is cut by 69% (basal) and 82% (food-stimulated). The effect can last up to 48 hours and settles at a steady state after 3 days. Acid output returns to normal over 2 to 3 days after stopping.
Domperidone present in Cyra-D Capsules blocks dopamine receptors in the gut and the vomiting trigger zone. It does not readily enter the brain. In studies it raised the pressure of the lower food pipe, improved stomach and duodenal movement, and sped up emptying, with no effect on acid.
Rabeprazole has about 52% bioavailability, peaks at about 3.5 hours, has a half-life near 1 hour, and is 97% protein bound. Domperidone has about 15% bioavailability, a half-life of 7 to 9 hours, and is 91% to 93% protein bound
Clinical Evidence
Item | Details |
Combination capsule | No efficacy trial of rabeprazole plus domperidone capsules is described. |
Domperidone safety trials | 1,275 patients aged 15 or older in 31 double-blind, placebo-controlled studies. Median daily dose 30 mg; median exposure 28 days. |
Higher doses of domperidone | In 45 other studies with higher doses and longer use, side effects were considerably more frequent, mainly those linked to prolactin. |
Rabeprazole stomach biopsies | Over 500 patients treated for up to 8 weeks showed no change in stomach cell structure. About 250 patients followed for 36 months showed no significant change. |
Heart risk | Epidemiological studies linked domperidone to serious ventricular arrhythmias and sudden cardiac death, mostly in people over 60, above 30 mg a day, or with QT-prolonging drugs or CYP3A4 blockers. |
QT and ketoconazole | Domperidone with ketoconazole raised the mean QTc by 9.8 msec, and with erythromycin by 9.9 msec. Domperidone alone raised it by 1.6 to 2.5 msec. |
Side Effects
The most common side effects of Cyra-D Capsules were headache, diarrhea, abdominal pain, weakness, wind, rash, and dry mouth. Most were mild or moderate and short-lived.
Frequency | Effects |
Common (fewer than 1 in 10) | Dry mouth, infections, difficulty sleeping, headache or dizziness, cough or sore throat, stomach pain, diarrhea, wind, nausea, vomiting, constipation, back pain, weakness, flu-like symptoms, benign stomach polyps |
Uncommon (fewer than 1 in 100) | Lower sex drive, anxiety, drowsiness, itching, milk production in men and women, painful breasts, bronchitis, sinusitis, indigestion, muscle or joint pain, hip, wrist or spine fractures, urinary infection, chest pain, chills, abnormal liver tests |
Rare (fewer than 1 in 1,000) | Loss of appetite, depression, allergy, visual disturbance, mouth sores, taste change, sweating, kidney problems, weight gain, low white cells or platelets |
Not known | Heart rhythm disorders, agitation, abnormal eye movements, inability to urinate, breast enlargement in men, irregular or stopped periods, low sodium, kidney injury, rash with joint pain |
Serious side effects
Serious effects are uncommon, but the heart, allergy, and kidney ones need quick action.
Heart rhythm (domperidone): QT prolongation, torsades de pointes, ventricular arrhythmias, and sudden cardiac death.
Allergy and skin: anaphylaxis, angioedema, hives, blistering reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, and subacute cutaneous lupus.
Nerve and movement: seizures and abnormal eye or tongue movements, mainly in children.
Blood and liver: low white cells or platelets, raised liver enzymes, hepatitis, jaundice, and rare liver brain disease in cirrhosis.
Long-term effects: low magnesium after 3 months or more, vitamin B12 deficiency, fractures after a year or more, and gut infections.
Critical Safety Warning
Call your local emergency number now for:
Do not take Cyra-D Capsules if you are pregnant, planning to become pregnant, or breastfeeding, or if you are allergic to domperidone, rabeprazole, other proton pump inhibitors, or any ingredient. Do not take it with a prolactin-secreting pituitary tumor or with bleeding, blockage, or a hole in the gut. Do not take it with moderate or severe liver disease, a long QT interval, heart failure, or abnormal potassium or magnesium levels. Do not take it with QT-prolonging drugs or strong CYP3A4 blockers. |
Dosage and How To Take It
Take one capsule of Cyra-D Capsules once a day, swallowed whole, 15 to 30 minutes before a meal, for the time your doctor sets.
Item | Details |
Veloz D (Torrent) | One capsule once daily, preferably before a meal or as the physician directs |
Repral-D (Torrent) | Once daily for 4 to 8 weeks |
Leaflet advice | Swallow whole with water 15 to 30 minutes before a meal. Do not crush or chew. Remove from the blister only when it is time to take it. |
Retail listing (1mg) | Take on an empty stomach, about one hour before a meal, preferably in the morning. This differs from Torrent. Follow the Cyra-D capsule insert and your doctor. |
Domperidone (UK labels) | 10 mg up to three times a day, maximum 30 mg a day, at the lowest effective dose, usually for no more than one week |
Kidney disease | For repeated doses, the interval of domperidone should be reduced to once or twice daily in severe impairment. |
Liver disease | Domperidone is contraindicated in moderate or severe liver impairment. Use rabeprazole with caution in severe liver disease. |
Children | Not to be used in children |
Limits of a fixed capsule: you cannot lower the domperidone dose or stop it while continuing the acid blocker. If your doctor wants a short domperidone course, ask about separate medicines.
Acid blockers and domperidone: antacids or antisecretory medicines lower the absorption of oral domperidone, which is present in Cyra-D Capsules. Ask your doctor about this combination.
Chromogranin A test: stop rabeprazole for at least 5 days before this test for neuroendocrine tumors.
Missed Dose
- Take the doses of Cyra-D Capsules as soon as you remember.
- If it is almost time for the next dose, wait until it is due and carry on as normal.
- Never take a double dose to make up.
Safety Advice
Inform your doctor about heart disease, fainting, palpitations, or low potassium/magnesium.
Use cautiously due to increased heart-related risks, especially above 30 mg/day of domperidone.
Use only after medical advice and risk-benefit assessment.
Consult your doctor before use.
May cause low magnesium, B12 deficiency, fractures, and gut infections.
Maintain adequate calcium and vitamin D intake if at risk of osteoporosis.
Check the ingredient list for lactose before use.
Avoid driving if you experience sleepiness or dizziness.
Inform the lab before a chromogranin A test.
Avoid prolonged use without medical advice.
Eat smaller meals, avoid trigger foods, and avoid eating 3–4 hours before bedtime.
Monitoring During Treatment
Check | Guidance | Why |
Reflux symptoms | Review after the course; stop when treated. | Avoid long use. |
Heart rhythm | Report palpitations, fainting, or breathlessness at once. UK NHS guidance suggests an ECG for people at risk | Domperidone risk |
Magnesium | Consider before and during long treatment, or with digoxin or diuretics. | Low magnesium |
Long-term review | Regular review for treatment over a year | Safety |
Vitamin B12 | Consider long use or risk factors. | Deficiency |
Blood and liver tests | Watch for infections, bruising, jaundice, or dark urine | Blood and liver effects |
Kidney function | Review if kidney symptoms appear or if there is severe impairment. | Dosing, nephritis |
Fact Box
Item | Detail |
Rabeprazole | Molecular weight 381.4; peak about 3.5 hours; half-life about 1 hour; 97% protein bound; CYP2C19 and CYP3A4; slow CYP2C19 metabolizers have about 1.9 times the exposure |
Domperidone | Molecular weight 425. 9; half-life 7 to 9 hours; moderate liver impairment raises exposure 2.9-fold |
Excretion | About 90% of a rabeprazole dose is left in urine as metabolites. Domperidone leaves 31% in urine and 66% in feces. |
Boxed warning | No box warning |
Overdose | No specific antidote. Rabeprazole is not dialysable. Domperidone overdose may cause drowsiness, confusion, movement problems, and QT prolongation, so an ECG is advised. |
Storage | Torrent Veloz D: below 25 degrees Celsius, protected from light and moisture |
Drug Interactions
Tell your doctor and pharmacist about every medicine you take
Drug / Category | Potential Risk | What To Do |
Azole antifungals (ketoconazole, fluconazole, voriconazole) | Increased domperidone levels and risk of heart rhythm problems | Avoid combination. |
Antibiotics (erythromycin, clarithromycin, telithromycin, moxifloxacin) | Increased risk of QT prolongation and irregular heartbeat | Avoid combination. |
Heart medicines (amiodarone, sotalol, quinidine, dofetilide) | Increased risk of serious heart rhythm disturbances | Avoid combination. |
Diltiazem and verapamil | May increase domperidone levels | Avoid unless approved by a specialist. |
Antipsychotics and antidepressants (haloperidol, pimozide, citalopram, escitalopram) | Increased risk of QT prolongation | Avoid combination. |
Other QT-prolonging medicines (cisapride, dolasetron, prucalopride, halofantrine) | Increased risk of abnormal heart rhythm | Avoid combination. |
HIV medicines (protease inhibitors, atazanavir, nelfinavir) | May increase domperidone levels or reduce antiviral absorption | Avoid or consult your doctor. |
High-dose methotrexate | May increase methotrexate levels and toxicity | Monitor levels; temporary interruption of rabeprazole may be considered. |
Ketoconazole and itraconazole | Rabeprazole may reduce antifungal absorption. | Monitor treatment effectiveness. |
Liquid antacids and amoxicillin | No significant interaction generally reported with rabeprazole | Use as prescribed. |
FAQs
Cyra-D capsule combines rabeprazole, which lowers stomach acid, with domperidone, which helps the stomach empty. Your doctor decides whether you need both.
It is not for self-treating ongoing heartburn.
References
Domperidone UK SmPCs: Zentiva 1 mg/ml oral suspension and domperidone 10 mg tablets (emc 14302) (search snippets).
National Library of Health. An Open-Label, Prospective, Single-Centre Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Rabeprazole (Enteric-Coated, EC) 20 mg + Domperidone (Sustained Release, SR) 30 mg Capsule in the Treatment of Patients with Laryngopharyngeal Reflux Disease. .
International of Pharmacy. RP-HPLC ANALYSIS FOR SIMULTANEOUS DETERMINATION OF
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)